HOOKHookipa Pharma Inc

$1.15
$0.01
(0.88%)
Today
Closed $1.15
$0.05
(4.35%)
After Hours
Updated: 04:01 PM EDT
Vol431.00

About

Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms. Hookipa´s TheraT® and Vaxwave® platforms have shown promising abilities to elicit high neutralizing antibody responses, but also necessary levels of T cell responses, currently missing in most vaccine and therapeutic approaches. Hookipa’s vectors are not impeded by vector-neutralizing antibodies and can be administered repeatedly, providing even greater immune protection. Levels of specific T cells generated by TheraT® are unprecedented in the field and have the potential to transform active immune-therapy in cancers. Hookipa has completed the active phase of a Phase 1 trial of a Vaxwave®-based vaccine against cytomegalovirus (CMV) and is finalizing clinical development plans for TheraT® in Human Papilloma Virus (HPV)- related head and neck cancers.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10

Frequently Asked Questions

What is the 52-week high for Hookipa Pharma Inc?
What is the 52-week low for Hookipa Pharma Inc?
What is Hookipa Pharma Inc stock price today?
What was Hookipa Pharma Inc stock price yesterday?
What is the PE ratio of Hookipa Pharma Inc?
What is the Price-to-Book ratio of Hookipa Pharma Inc?
What is the 50-day moving average of Hookipa Pharma Inc?
How many employees does Hookipa Pharma Inc have?

Latest HOOK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.